Skip to main content
Year archive

THERACRYF PLC — 2021 filings

All 50 regulatory filings released by THERACRYF PLC (TCF) in 2021, sourced directly from the official regulator.

50 Filings
2021 Period
2021 filings (50)
Filing Released Lang
Holding(s) in Company
Major Shareholding Notification
2021-12-30 English
Grant of Options
Director's Dealing
2021-12-08 English
Half-year Report
Interim / Quarterly Report H1 2021
2021-12-07 English
Notice of Results
Report Publication Announcement
2021-11-23 English
Publication of data on SFX-01 in glioblastoma
Regulatory Filings
2021-11-10 English
Holding(s) in Company
Major Shareholding Notification
2021-10-19 English
Publication of data in glioblastoma cells
Regulatory Filings
2021-09-20 English
Holding(s) in Company
Major Shareholding Notification
2021-09-02 English
Second Price Monitoring Extn
Regulatory Filings
2021-09-02 English
Price Monitoring Extension
Regulatory Filings
2021-09-02 English
Second Price Monitoring Extn
Regulatory Filings
2021-09-02 English
Glioma Orphan Drug designation granted by FDA
Regulatory Filings
2021-09-02 English
Price Monitoring Extension
Regulatory Filings
2021-09-02 English
Holding(s) in Company
Major Shareholding Notification
2021-08-25 English
Second Price Monitoring Extn
Regulatory Filings
2021-08-24 English
Price Monitoring Extension
Regulatory Filings
2021-08-24 English
Holding(s) in Company
Major Shareholding Notification
2021-08-09 English
Holding(s) in Company
Major Shareholding Notification
2021-07-20 English
Holding(s) in Company
Major Shareholding Notification
2021-07-16 English
Holding(s) in Company
Major Shareholding Notification
2021-07-14 English
Result of AGM and Business Update
AGM Information
2021-07-13 English
Holding(s) in Company
Major Shareholding Notification
2021-07-13 English
Early data for SFX-01 in leukaemia cell lines
Regulatory Filings
2021-07-13 English
Glioma Orphan Drug application submitted to US FDA
Regulatory Filings
2021-07-13 English
Second Price Monitoring Extn
Regulatory Filings
2021-07-09 English
Price Monitoring Extension
Regulatory Filings
2021-07-09 English
Interim Safety and Futility Analysis - STAR trial
Regulatory Filings
2021-07-09 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement
2021-06-18 English
Final Results
Annual Report FY 2021
2021-06-15 English
Progress on metastatic breast cancer programme
Regulatory Filings
2021-06-14 English
Progress with Glioma/Glioblastoma programme
Regulatory Filings
2021-06-14 English
Appointment of Chief Medical Officer
Board/Management Information
2021-04-26 English
Publication on sulforaphane in COVID-19
Regulatory Filings
2021-04-07 English
Appointment of Chief Business Officer
Board/Management Information
2021-03-22 English
Holding(s) in Company
Major Shareholding Notification
2021-03-15 English
Update on Data Safety Review - STAR COVID-19 trial
Regulatory Filings
2021-03-11 English
Holding(s) in Company
Major Shareholding Notification
2021-03-09 English
Holding(s) in Company
Major Shareholding Notification
2021-03-08 English
Holding(s) in Company
Major Shareholding Notification
2021-03-05 English
Director dealing
Director's Dealing
2021-03-05 English
Result of General Meeting & Total Voting Rights
Regulatory Filings
2021-03-03 English
Result of Open Offer
Capital/Financing Update
2021-03-03 English
Holding(s) in Company
Major Shareholding Notification
2021-02-26 English
Holding(s) in Company
Major Shareholding Notification
2021-02-17 English
Update on patient recruitment
Regulatory Filings
2021-02-17 English
Posting of Circular & Notice of GM
Regulatory Filings
2021-02-12 English
Placing and Open Offer to raise up to £11 million
Capital/Financing Update
2021-02-02 English
Preclinical data on a new therapeutic target
Regulatory Filings
2021-01-22 English
Positive pre-clinical data for lead asset SFX-01
Regulatory Filings
2021-01-21 English
Patient recruitment update in STAR-COVID 19 trial
Regulatory Filings
2021-01-19 English